The dynamics of cortical and hippocampal atrophy in Alzheimer disease

Archives of Neurology

Volumn 68, Issue 8, 2011, Pages 1040-1048

  Sabuncu, Mert R ^a,c   Desikan, Rahul S ^a,b   Sepulcre, Jorge ^a,d,e   Yeo, Boon Thye T ^a,d   Liu, Hesheng ^a   Schmansky, Nicholas J ^a   Reuter, Martin ^a   Weiner, Michael W ^f,g   Buckner, Randy L ^a,d,e   Sperling, Reisa A ^a   Fischl, Bruce ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD UNIVERSITY   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX ATROPHY; CANADA; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; CASE-CONTROL STUDIES; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVE DEGENERATION;

EID: 80051553765     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.167     Document Type: Article

References (42)

1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-259.
2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991; 1(1):103-116.
3. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging. 1997;7(6):1069-1075. (Pubitemid 28372883)
4. Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology. 1999;52(8):1687-1689. (Pubitemid 29220648)
5. Jack CR Jr, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004; 62(4):591-600. (Pubitemid 38252801)
6. Jack CR Jr, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005; 65(8):1227-1231. (Pubitemid 41508215)
7. Jack CR Jr, Weigand SD, Shiung MM, et al. Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology. 2008;70(19, pt 2):1740-1752. (Pubitemid 351653966)
8. Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM; Alzheimer's Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer's disease [published correction appears in Proc Natl Acad Sci U S A. 2010;107(14):6551]. Proc Natl Acad Sci U S A. 2009;106(49):20954-20959.
9. Whitwell J, Przybelski S, Weigand S, et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain. 2007;130(pt 7):1777-1786. (Pubitemid 47343806)
10. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain. 1996;119(pt 6): 2001-2007.
11. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A. 2002;99(7):4703-4707. (Pubitemid 34286048)
12. Schuff N, Woerner N, Boreta L, et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain. 2009; 132(pt 4):1067-1077.
13. Frisoni G, Fox N, Jack C, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Nephrol. 2010;6(2):67-77.
14. Ridha BH, Barnes J, Bartlett JW, et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 2006;5(10):828-834. (Pubitemid 44715810)
15. Narr KL, Toga AW, Szeszko P, et al. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry. 2005;58(1):32-40. (Pubitemid 40909933)
16. Shaw P, Kabani NJ, Lerch JP, et al. Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci. 2008;28(14):3586-3594.
17. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49(3):786-794. (Pubitemid 27428023)
18. Chan D, Janssen JC, Whitwell JL, et al. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet. 2003; 362(9390):1121-1122. (Pubitemid 37222338)
19. Rusinek H, Endo Y, De Santi S, et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology. 2004;63(12):2354-2359. (Pubitemid 40024349)
20. Sluimer JD, van der Flier WM, Karas GB, et al. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur Radiol. 2009; 19(12):2826-2833.
21. Amieva H, Jacqmin-Gadda H, Orgogozo J-M, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005;128(pt 5):1093-1101. (Pubitemid 40675464)
22. Stern Y, Liu X, Albert M, et al. Application of a growth curve approach to modeling the progression of Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 1996; 51(4):M179-M184. (Pubitemid 26256324)
23. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1): 119-128.
24. Caroli A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative. The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging. 2010;31(8):1263-1274.
25. Bass F. Comments on "A New Product Growth for Model Consumer Durables: The Bass Model." Manage Sci. 2004;50(12):1833-1840. (Pubitemid 40086731)
26. Sabuncu MR, Desikan RS, Sepulcre J, et al. The cumulative diffusion model. Harvard University Web site. ftp://surfer.nmr.mgh.harvard.edu/pub/ articles /Sabuncu-ArchivesOfNeurology-2011-Supplemental.pdf. Accessed October 27, 2010.
27. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol. 2009;65(4):403-413.
28. 42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64(3):343-349.
29. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414. (Pubitemid 23346995)
30. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3):183-194. (Pubitemid 39222988)
31. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis, II: inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9(2):195-207. (Pubitemid 29369875)
32. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97(20):11050- 11055.
33. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341-355. (Pubitemid 34162530)
34. Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage. 2004;23(2):724-738. (Pubitemid 39370623)
35. Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL. Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. J Cogn Neurosci. 2007; 19(9):1498-1507. (Pubitemid 47358152)
36. Fischl B, Sereno MI, Tootell RBH, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 1999; 8(4):272-284.
37. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40(7):812.
38. Draper NR, Smith H. Applied Regression Analysis. New York: John Wiley & Sons; 1966.
39. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497-510.
40. Desikan RS, Sabuncu MR, Schmansky NJ, et al Alzheimer's Disease Neuroimaging Initiative. Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One. 2010;5(9):e12853. doi:10.1371/journal.pone. 0012853.
41. Becker JA, Hedden T, Carmasin J, et al. Amyloid-β associated cortical thinning in clinically normal elderly [published online November 17, 2010]. Ann Neurol. doi:10.1002/ana.22333/full.
42. Mormino EC, Kluth JT, Madison CM, et al Alzheimer's Disease Neuroimaging Initiative. Episodic memory loss is related to hippocampal-mediated β-amyloid deposition in elderly subjects. Brain. 2009;132(pt 5):1310-1323.